465 related articles for article (PubMed ID: 19201187)
1. The molecular determinants of de novo nucleotide biosynthesis in cancer cells.
Tong X; Zhao F; Thompson CB
Curr Opin Genet Dev; 2009 Feb; 19(1):32-7. PubMed ID: 19201187
[TBL] [Abstract][Full Text] [Related]
2. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
3. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
6. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
[TBL] [Abstract][Full Text] [Related]
7. Carbon source metabolism and its regulation in cancer cells.
Yin C; Qie S; Sang N
Crit Rev Eukaryot Gene Expr; 2012; 22(1):17-35. PubMed ID: 22339657
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.
Mitsuishi Y; Taguchi K; Kawatani Y; Shibata T; Nukiwa T; Aburatani H; Yamamoto M; Motohashi H
Cancer Cell; 2012 Jul; 22(1):66-79. PubMed ID: 22789539
[TBL] [Abstract][Full Text] [Related]
9. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
10. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic regulation of tumor metabolic reprogramming.
Tarrado-Castellarnau M; de Atauri P; Cascante M
Oncotarget; 2016 Sep; 7(38):62726-62753. PubMed ID: 28040803
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
13. MYC and metabolism on the path to cancer.
Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
[TBL] [Abstract][Full Text] [Related]
14. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
Lien EC; Lyssiotis CA; Cantley LC
Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
[TBL] [Abstract][Full Text] [Related]
16. The phosphatidylinositol 3-kinase/akt cassette regulates purine nucleotide synthesis.
Wang W; Fridman A; Blackledge W; Connelly S; Wilson IA; Pilz RB; Boss GR
J Biol Chem; 2009 Feb; 284(6):3521-8. PubMed ID: 19068483
[TBL] [Abstract][Full Text] [Related]
17. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
[TBL] [Abstract][Full Text] [Related]
18. Brick by brick: metabolism and tumor cell growth.
Deberardinis RJ; Sayed N; Ditsworth D; Thompson CB
Curr Opin Genet Dev; 2008 Feb; 18(1):54-61. PubMed ID: 18387799
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
20. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
